[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100545136":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":19,"centralContacts":20,"locations":26,"responsibleParty":44,"collaborators":19,"id":48,"slug":19,"hasResults":49,"nctId":50,"briefTitle":51,"officialTitle":51,"acronym":19,"eligibilityCriteria":52,"healthyVolunteers":49,"sex":53,"minAge":54,"maxAge":19,"enrollmentInfo":55,"targetDuration":19,"studyType":58,"phases":59,"briefSummary":61,"conditions":62,"keywords":19,"overallStatus":29,"whyStopped":19,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":65,"startDateStruct":68,"completionDateStruct":70,"leadSponsor":72,"locationsCount":73},{"fullName":5,"class":6},"Stanford University","OTHER",[8],{"label":9,"type":6,"description":10,"interventionNames":11},"Treatment","Patient will go through trial of spinal cord stimulator. If trial results in \\>50% reduction in pain, they will receive implantable spinal cord stimulator",[12],"Device: ECAP (Evoked Compound Action Potential)-controlled Closed-Loop Spinal Cord Stimulation",[14],{"type":15,"name":16,"description":17,"armGroupLabels":18,"otherNames":19},"DEVICE","ECAP (Evoked Compound Action Potential)-controlled Closed-Loop Spinal Cord Stimulation","The patients will receive externalized epidural leads connected to external pulse generator for 5-14 days during trial phase. If the trial results in \\>50% reduction in pain, they will undergo a minor surgery to receive implantable spinal cord stimulator",[9],null,[21],{"name":22,"role":23,"phone":24,"phoneExt":19,"email":25},"Vafi Salmasi, MD","CONTACT","6507250246","vsalmasi@stanford.edu",[27],{"facility":28,"status":29,"city":30,"state":31,"zip":32,"country":33,"countryCode":34,"cosmosGeoPoint":35,"geoPoint":40,"contacts":41},"Stanford","RECRUITING","Redwood City","California","94063","United States","US",{"type":36,"coordinates":37},"Point",[38,39],-122.23635,37.48522,{"lat":39,"lon":38},[42],{"name":22,"role":23,"phone":43,"phoneExt":19,"email":25},"650-725-0246",{"type":45,"investigatorFullName":46,"investigatorTitle":47,"investigatorAffiliation":5,"oldNameTitle":19,"oldOrganization":19},"PRINCIPAL_INVESTIGATOR","Vafi Salmasi","Assistant Professor","100545136",false,"NCT06377969","Prospective Evaluation of Effectiveness and Safety of Closed-Loop Spinal Cord Stimulation in Treating Patients With Chronic Pelvic Pain","Inclusion Criteria:\n\nThe investigators will include all adult patients (18 or older) with pelvic pain more than 6 months that has not responded to conservative medical management\n\nExclusion Criteria:\n\n* Major untreated medical comorbidities (uncontrolled diabetes mellitus, severe obesity, uncontrolled cardiopulmonary disease, etc.)\n* Secondary causes of pelvic pain that can be treated with appropriate medical or surgical interventions\n* Major untreated psychological comorbidities\n* Anatomical challeneges to place spinal cord stimulator\n* Ongoing legal or disability claims","ALL","18 Years",{"count":56,"type":57},10,"ESTIMATED","INTERVENTIONAL",[60],"NA","Spinal cord stimulation (SCS) is an effective treatment for patients with chronic pelvic pain. The investigators will evaluate how safe and effective closed-loop spinal cord stimulation is in treating these patients; closed-loop spinal cord stimulation is a more novel method in delivering spinal cord stimulation that controls energy output of the device based on real-time feedback on how the device is stimulating the spinal cord.",[63],"Chronic Pelvic Pain Syndrome","2026-03-09",{"date":66,"type":67},"2026-03-11","ACTUAL",{"date":69,"type":67},"2025-06-01",{"date":71,"type":57},"2028-05-31",{"name":5,"class":6},1]